Empowered! - The Podcast is a podcast feed where the latest Empowered! articles are read aloud. This is for all those people who would prefer to listen to my content, and is also perfect for sharing with your friends and family who insist that they “don’t have time to read”.
To view the sources (links to articles, graphs, and images) that I referenced in this article, please visit the text version of this post:
GLP-1 agonist weight loss drugs: Leaning the ladder against the wrong wall
In his best-selling book The 7 Habits of Highly Effective People, Stephen Covey cautioned against a common trap: "work[ing] harder and harder at climbing the ladder of success only to discover it’s leaning against the wrong wall." In other words, one should spend some time clarifying what "success" means, before one invests time, money and energy into pursuing it. At this point in my mini-series on GLP-1 agonists such as Ozempic, Wegovy and Saxenda, it's appropriate to ask which wall these drugs are leaning against.
As always, your feedback is greatly appreciated:
